S&P 500 7,656.21 +0.43%
Nasdaq 26,038.70 +0.32%
S&P/TSX 35,893.88 +0.30%
Apple 341.28 −1.85%
Nvidia 215.61 +2.20%
Microsoft 523.17 −0.26%
Shopify 235.37 −0.37%
Royal Bank 283.78 +0.71%
CAD/USD 0.7124 −0.25%
LIVE · 09:50 ET
Market ClerkRecap
Mon Oct 26 · markets open1 signal today94 insider buys this week · $48.3MCIRO short report next: Oct 31The week ahead
PD
INSIDER · PTGX · Protagonist Therapeutics, Inc · PRESIDENT AND CEO

PATEL DINESH V PH D

Every open-market transaction filed under this name, Sep 8 to Sep 10.

Filings
3
0 buys · 3 sells
Bought
—
open market, at cost
Sold
$18.2M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 10PTGXProtagonist Therapeutics, IncPresident and CEOSell7,278$144.10$1M—
Sep 9PTGXProtagonist Therapeutics, IncPresident and CEOSell63,548$146.18$9.3M—
Sep 8PTGXProtagonist Therapeutics, IncPresident and CEOSell54,174$145.87$7.9M—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.